Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry Study to Surveil Early Liver Injuries Caused by Runzao Zhiyang Capsule (RZZY Capsule).

NCT03091218 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT03091218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03091218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry Study to Surveil Early Liver Injuries Caused by Runzao Zhiyang Capsule (RZZY Capsule).
Lead sponsor
Beijing 302 Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 25, 2017
Completion date
December 31, 2017
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced liver injury